Aequus Depreciation And Amortization from 2010 to 2024
| AQS Stock | CAD 0.01 0.00 0.00% |
Depreciation And Amortization | First Reported 2013-09-30 | Previous Quarter 33.9 K | Current Value 33.1 K | Quarterly Volatility 85.9 K |
Check Aequus Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aequus Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 155.3 K, Interest Expense of 175.2 K or Selling General Administrative of 2.2 M, as well as many indicators such as Price To Sales Ratio of 10.77, Dividend Yield of 0.0 or Days Sales Outstanding of 43.11. Aequus financial statements analysis is a perfect complement when working with Aequus Pharmaceuticals Valuation or Volatility modules.
Aequus | Depreciation And Amortization |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aequus Stock Analysis
When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.